“fda” Archives

in
Entry Author Date Location
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Hologic Expands Into Medical Aesthetics With $1.4B Cynosure Deal 02/14/17 Boston
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs 02/13/17 Wisconsin
Allergan to Acquire Fat-Busting Medical Tech Firm Zeltiq for $2.4B 02/13/17 San Francisco
Dear Tom Price: Bundled Payments Help Patients and Reduce Costs 02/11/17 Boston
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Senate Confirms Price for HHS, But Stock Deals Still Raise Questions 02/10/17 National
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof 02/02/17 Boston
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Seres Dissects Failed Microbiome Drug Trial, Suggests Changes to FDA 01/31/17 Boston
Novan Acne Drug Hits Targets in One Late-Stage Trial, Fails Another 01/27/17 Raleigh Durham
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Mallinckrodt Filing Pegs Stratatech Deal at $76M, Could Reach $197M 01/26/17 Wisconsin
AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut 01/26/17 San Diego
Anthem Caps Coverage Of Biogen Spine Drug Despite Wide FDA Approval 01/24/17 Boston
Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy 01/24/17 Boston
Ex-FDA Commish Califf Gives Props to Patient Groups—With Caveats 01/23/17 National
Elucent, With $7.2M in Tow, Advances Breast Cancer Treatment Device 01/20/17 Wisconsin
Business Leaders Talk Trump’s Impact on Visas, Drug Pricing, Insurance 01/20/17 National
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug 01/17/17 Boston
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA 01/12/17 Boston
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial 01/10/17 San Francisco
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio 01/09/17 Boston
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Biopharma Industry, Heal Thyself (Without Government Help) 01/06/17 San Diego
Page 3 of 59 « previous page · next page »